Celltrion Announces Launch of AVTOZMA® (tocilizumab-anoh) Intravenous Formulation in the United States
… biosimilar to ACTEMRA® in the United States. AVTOZMA® is supplied as an … to be launched in the United States, after Biogen’s TOFIDENCE® (tocilizumab …








